Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis
-
Published:2021-09
Issue:3
Volume:100
Page:702-704
-
ISSN:0085-2538
-
Container-title:Kidney International
-
language:en
-
Short-container-title:Kidney International
Author:
Ducloux DidierORCID,
Colladant Mathilde,
Chabannes Melchior,
Yannaraki Maria,
Courivaud Cécile
Reference7 articles.
1. COVID-19 in dialysis patients: outlasting and outsmarting a pandemic;Hsu;Kidney Int,2020
2. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients;Litjens;J Am Soc Nephrol,2008
3. Humoral response to SARS-CoV-2-vaccination with BNT162b2 (Pfizer-BioNTech) in patients on hemodialysis;Jahn;Vaccines (Basel),2021
4. Frantzen L, Cavaille G, Thibeaut S, El-Haik Y. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in a hemodialysis cohort [e-pub ahead of print]. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfab165. Accessed July 13, 2021.
5. Lacson E, Argyropoulos CP, Manley HJ, et al. Immunogenicity of SARS-CoV-2 vaccine in dialysis [preprint]. medRxiv. https://doi.org/10.1101/2021.04.08.21254779. Accessed July 13, 2021.
Cited by
97 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献